Latest radiotherapy Stories

Clinicians at The Ohio State University are now using Varian software to manage patient treatments on a Siemens ONCOR medical linear accelerator PALO ALTO, Calif., June 13, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) and Siemens Healthcare today announced that clinicians at The Ohio State University (Ohio State) are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator. The companies have developed and...

In a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG), high-dose (HD), compared with standard-dose (SD), radiotherapy (RT) with concurrent chemotherapy (CT) did not improve overall survival of patients with stage III non-small-cell lung cancer (NSCLC). Of all the patients in the US with lung cancer, the country's leading cause of cancer death, 75 to 80 percent of them have NSCLC, with 30 to 40 percent of those being considered locally advanced...

Revolutionary technology enables higher quality cancer care for patients in Yorkshire LEEDS, England, May 27, 2013 /PRNewswire/ -- St James's Institute of Oncology, a leading radiotherapy center in the UK, recently ordered two Versa HD(TM) systems, an advanced linear accelerator designed to improve patient care and treat a wide range of tumors throughout the body. As the latest, most sophisticated cancer treatment system on the market, Versa HD can help maximize health care...

redOrbit Staff & Wire Reports - Your Universe Online The discovery that mouse hair operates on a circadian clock has given researchers hope that cancer radiotherapy and chemotherapy could be scheduled later in the day in order to minimize hair loss in patients. According to the study, which was published online Monday in the Proceedings of the National Academy of Sciences (PNAS), experts from the Salk Institute for Biological Studies, the University of Southern California (USC) and...

BEIJING, May 15, 2013 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital, today announced that the Company has signed a US$50 million loan package agreement with IFC (International Financial Corporation), the member of the World Bank Group...

Conference call to discuss results will be held on May 22, 2013 BEIJING, May 10, 2013 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE:CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it will release its financial results for the first quarter of 2013 after the market closes, at 6:00pm EDT on May 21, 2013....

BEIJING, May 2, 2013 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading hospital management company and the operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced it filed its Annual Report on Form 20-F that included audited financial statements for the year ended December 31, 2012 with the U.S. Securities and Exchange Commission on April 26, 2013. An electronic version...

Oncology Departments in North Middlesex and Poole Acquire Final Two TrueBeam Systems Made Available Under NHS Supply Chain Initiative CRAWLEY, U.K., April 29, 2013 /PRNewswire/ -- Hospitals in London and Dorset have acquired the final two of ten advanced Varian Medical Systems (NYSE: VAR) radiotherapy treatment machines offered as part of an innovative government program to roll out the most modern cancer treatments for patients in the UK's public hospitals. North Middlesex...

Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumor, and with fewer serious side-effects to the surrounding normal organs. In two presentations today (Saturday) and tomorrow (Sunday) researchers will tell the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) that image-guided brachytherapy is able to deliver very high doses, which prevent the tumor from growing...

Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumor is kept to the minimum. The largest study yet to show a correlation between radiation doses to the submandibular glands and their output of saliva was presented today (Saturday) at the 2nd Forum of the European...